Synonyms
Status
Molecule Category UNKNOWN
UNII 0OJB0LES1A

Structure

InChI Key CFKBNYUHQSQBSX-CYWCHRQTSA-N
Smiles O=C(CNC(=O)c1cccc(C(F)(F)F)c1)NC1CN([C@H]2CC[C@@](O)(c3cncs3)CC2)C1
InChI
InChI=1S/C22H25F3N4O3S/c23-22(24,25)15-3-1-2-14(8-15)20(31)27-10-19(30)28-16-11-29(12-16)17-4-6-21(32,7-5-17)18-9-26-13-33-18/h1-3,8-9,13,16-17,32H,4-7,10-12H2,(H,27,31)(H,28,30)/t17-,21-

Physicochemical Descriptors

Property Name Value
Molecular Formula C22H25F3N4O3S
Molecular Weight 482.53
AlogP 2.52
Hydrogen Bond Acceptor 6.0
Hydrogen Bond Donor 3.0
Number of Rotational Bond 6.0
Polar Surface Area 94.56
Molecular species NEUTRAL
Aromatic Rings 2.0
Heavy Atoms 33.0

Bioactivity

Mechanism of Action Action Reference
C-C chemokine receptor type 2 antagonist ANTAGONIST PubMed
Protein: C-C chemokine receptor type 2

Description: C-C chemokine receptor type 2

Organism : Homo sapiens

P41597 ENSG00000121807
Assay Description Organism Bioactivity Reference
Antiasthamatic activity in ovalbumin-sensitized mouse model assessed as inhibition of airway eosinophil infiltration at 10 mg/kg, po bid Mus musculus 89.0 %
Inhibition of human ERG expressed in HEK-293 cells assessed as K+-selective outward current at 3 uM at -80 mV holding potential after 5 mins by voltage patch-clamp method Homo sapiens 21.0 %
Antagonist activity against CCR2 in human THP-1 cells assessed as inhibition of MCP-1 induced chemotaxis after 3 hrs Homo sapiens 30.0 nM
Displacement of [125I]-MCP-1 from CCR2 in human THP-1 cells after 2 hrs by microplate scintillation and luminescence counter analysis Homo sapiens 37.0 nM

Cross References

Resources Reference
ChEMBL CHEMBL2204263
DrugBank DB12632
FDA SRS 0OJB0LES1A
PubChem 46208367
SureChEMBL SCHEMBL2545786
ZINC ZINC000141611914